Diabetes

Latest News



Patients at high risk - including those with cancer, diabetes, and cardiovascular disease - will be covered under the Pre-Existing Condition Insurance Plan (PCIP) until March 31, thanks to a decision this week from the Department of Health and Human Services.

Healthcare reform is already presenting new challenges and opportunities for endocrinology, a specialty that is under significant stress in the United States. A critical workforce shortage has drained the pool of practicing endocrinologists, just as the Affordable Care Act (ACA) is expected to send millions of newly insured people into the system.

This month's edition of Evidence-Based Diabetes Management, a news source of The American Journal of Managed Care, examines the science behind Mayor Michael Bloomberg's pursuit of soda portion limits, as well as alternatives for curtailing consumption to fight obesity. Soon after Mayor-elect de Blasio takes office, he must decide how to achieve Bloomberg's goal, including whether to continue litigation before the New York State Court of Appeals.

The long-awaited update to guidelines for the management of hypertension - from the panel appointed to the Eighth Joint National Committee (JNC 8) - raises the recommended blood pressure threshold to determine the need for drug therapy in many patients.

To build on the success and ideas generated at last year's inaugural event, Joslin Diabetes Center once again brought together numerous key stakeholders in the collective battle to conquer diabetes and to provoke thought, innovation, and action. Highlights from Diabetes Innovation, which took place on October 3-5, 2013, in Washington, DC, are available in a special report published by The American Journal of Managed Care.

In an effort to avoid a coverage gap in health insurance, those covered under the Pre-existing Condition Insurance Plan (PCIP) will get until January 2014 to enroll into a new plan through the state or federal healthcare exchange website.

Whereas population health focuses on the outcomes within a specific group, personalized medicine seeks to customize care delivery at the individual level. A recent discussion between Dr Eric Topol, director, Scripps Translational Science Institute, and Dr Farzad Mostashari, former director of the Office of the National Coordinator for Health Information Technology, highlighted the diverging opinions of where future healthcare models need to go.

In this interview, Curtis Triplitt, PharmD, associate professor and assistant dean of research, Texas Tech University Health Sciences Center, Permian Basin, explains why diabetes should be treated with a patient-centered approach.

Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text